7702
Fiscal year ends March Quarters are offset from the calendar — Q1 is Apr–Jun

Jms Co., Ltd. is a manufacturer and distributor of disposable medical devices and pharmaceuticals. The company operates through a group structure that includes ten consolidated subsidiaries and two equity-method affiliates. Its primary business segment involves the production and sale of medical supplies, with domestic operations managed by the parent company and the equity-method affiliate J.O. Pharma. International activities are conducted through subsidiaries in Singapore, China, the Philippines, Germany, the United States, South Korea, and Thailand. Key overseas entities include JMS Singapore PTE. LTD., PT JMS Batam, Dalian JMS Medical Devices Co., Ltd., JMS Healthcare Philippines, Inc., and Bionic Medizin Technik GmbH. The group also engages in maintenance services and other related activities, with domestic operations in this area handled by the subsidiary JMS Teijin Home Medical Care Co., Ltd. Founded in 1965 under the name Japan Medical Supply Co., Ltd., the company shifted its corporate name to JMS Co., Ltd. in 2010. The business focuses on providing single-use, sterile medical products to healthcare providers and patients.

Summarised from the annual report, fiscal year ended Mar 2026

Industry Medical Devices Homepage jms.cc
Sector Healthcare IR page jms.cc/ir
Tags
disposable medical devices, pharmaceuticals, medical supplies, home medical care, maintenance services, J.O. Pharma, JMS Singapore PTE. LTD., PT JMS Batam, Dalian JMS Medical Devices Co. Ltd., JMS Healthcare Philippines Inc., Bionic Medizin Technik GmbH, JMS Teijin Home Medical Care Co. Ltd., JMS North America Corporation, JMS Healthcare Thailand Co. Ltd., JMS Medical Technology (Zhangjiagang) Co. Ltd.
Press page —

Metrics

Valuation  
Market cap ¥ 11.13B
Market cap (USD) $ 69.564M
P/E -12.90
PEG —
P/BV 0.27
P/S 0.17
P/OCF 3.81
P/FCF 51.77
Dividend yield 3.8%
Turnover / mcap —
Returns  
ROE -1.9%
ROI -1.3%
ROIC 0.46%
Profit margin -1.2%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score -50.0%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Revenue 65.845B 69.749B 65.292B 63.74B 58.169B 57.578B 58.569B 58.059B 56.52B 55.574B 57.636B 55.401B 53.86B 49.068B
Net profit -783M 89M -36M 281M 826M 1.736B 1.977B 1.16B 631M 1.182B 754M 139M 207M 1.277B
Free cash flow -1.075B -1.573B 498M -1.071B 1.138B 481M 263M 1.366B -134M -167M -1.83B — — —

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Share price 425.05 461.09 534.58 523.25 609.84 976.33 875.25 670.55 627.32 336.05 590.43 589.56 614.36 359.1
Price performance 12m -0.08 -0.14 0.02 -0.14 -0.38 0.12 0.31 0.07 0.87 -0.43 0 -0.04 0.71 —

Filed figures

Figure Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Balance sheet detail
Trade receivables (JPY) 15.4B 16.5B 15.8B 15.7B 16.4B 16.1B 17.2B 18.3B 18.6B 18.7B
↳ YoY growth -2.3% +7.1% -3.7% -1.0% +4.7% -2.1% +7.0% +6.4% +1.8% +0.1%
↳ 5y CAGR +0.9% +0.9% +0.9% +2.9% +3.5% +2.6%
Borrowings, current (JPY) 6.04B 7.04B 7.7B 7.59B 8.41B 8.05B 7.92B 14.4B 11.1B 14.5B
Borrowings, non-current (JPY) 11.6B 12B 10.6B 9.99B 9.34B 10.1B 11.6B 11.1B 11.8B 12B
Lease liabilities (JPY) 165M 708M 595M 873M 753M 549M 231M 1.49B 1.68B 1.53B
Cash and deposits (JPY) 6.27B 7.16B 7.08B 5.77B 5.97B 6.61B 6.33B 10.3B 5.51B 7.72B
Intangible assets (JPY) 448M 438M 503M 538M 692M 1.04B 847M 995M 943M 982M
Net debt (borrowings + leases - cash) (JPY) 11.4B 12.5B 11.8B 12.7B 12.5B 12.1B 13.4B 16.6B 19B 20.3B
Cash flow detail
Operating cash flow (JPY) 4.68B 2.67B 4.35B 3.57B 3.74B 4.4B 2.49B 3.14B 1.47B 1.58B
Purchases of property, plant and equipment (JPY) -4.74B -2.8B -2.82B -3.12B -2.99B -2.86B -3.51B -2.55B -2.9B -2.48B
Purchases of intangible assets (JPY) -98M -136M -164M -185M -270M -404M -45M -89M -142M -183M
Change in receivables (cash effect) (JPY) -19M -1.08B 592M 231M -529M 526M -818M -319M -303M 490M
Change in inventories (cash effect) (JPY) -770M -93M -669M -1.13B -895M -110M -576M -360M -1.51B 1.28B
Change in payables (cash effect) (JPY) 321M -259M 193M -262M -222M 55M 99M -171M -833M -2.38B
Dividends paid (cash effect) (JPY) -485M -390M -392M -390M -427M -414M -415M -415M -416M -416M
Share buybacks (cash effect) (JPY) -2M -1M 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest paid (cash effect) (JPY) -127M -127M -191M -199M -176M -161M -169M -187M -370M -407M
Income taxes paid (cash effect) (JPY) -278M -424M -269M -456M -698M -405M -248M -226M -486M -663M
Operating cash flow before change in receivables (JPY) 4.69B 3.75B 3.76B 3.33B 4.27B 3.87B 3.3B 3.46B 1.77B 1.09B
Free cash flow (OCF - PPE - intangibles) (JPY) -167M -270M 1.37B 263M 481M 1.14B -1.07B 498M -1.57B -1.08B
Income detail
Research and development expense (JPY) 1.46B 1.55B 1.52B 1.42B 1.6B 1.53B 1.32B 1.52B 1.53B 1.61B
↳ 5y CAGR +4.9% +0.9% -3.2% +0.0% +1.6% +0.1%
Total comprehensive income (JPY) 640M 880M 727M 945M 2.91B 2.52B 1.96B 2.43B 584M 1.26B
Comprehensive income to owners (JPY) 627M 882M 728M 946M 2.89B 2.53B 1.98B 2.43B 666M 1.29B
Provision for credit losses (JPY) 0.00 10M — — — 93M 5M 17M -45M -3M
Credit cost ratio (credit losses / average receivables) (%) 0.0% 0.1% — — — 0.6% 0.0% 0.1% 0.2% 0.0%
Reported Jun 22, 2018 Jun 22, 2018 Jun 26, 2019 Jun 26, 2020 Jun 24, 2021 Jun 23, 2022 Jun 28, 2023 Jun 26, 2024 Jun 25, 2025 Jun 22, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

2027年3月期第2四半期連結決算の概要 Bull 2 Bear 4 Results

Prompts

Jms Co., Ltd. (ticker 7702), listed in Japan.

ETFs Holding Jms Co., Ltd.

ETF Weight in ETF Shares Market value As of
DISV 0.00% 18,900 $ 50.944K Nov 12, 2026
DFIC 0.00% 17,545 $ 47.291K Nov 12, 2026
DFAX 0.00% 10,197 $ 27.485K Nov 12, 2026
DFIS 0.00% 3,200 $ 8,625.39 Nov 12, 2026